Skip to content

Clinical trials

Active, not recruiting Endometrial Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Status: Active, not recruiting Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20194
20203
20213
20223
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
AstraZeneca2
National Cancer Institute (NCI)2
ARCAGY/ GINECO GROUP1
AbbVie1
Eisai Inc.1
Eli Lilly and Company1
Gilead Sciences1
GlaxoSmithKline1
Institute of Cancer Research, United Kingdom1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms20
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms4
Ovarian Neoplasms4
Uterine Cervical Neoplasms4
Breast Neoplasms3
Carcinosarcoma3
Neoplasm Metastasis3
Stomach Neoplasms3
Biliary Tract Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.